Want to see IN:NATHBIOGEN full AI Analyst Report?

Nath Bio-Genes (India) Ltd. (NATHBIOGEN) Price & Analysis

3 Followers

NATHBIOGEN Stock Chart & Stats

₹165.50

-₹1.00(-0.61%)

At close: Jul 28 4:00 PM EDT

₹165.50

-₹1.00(-0.61%)

Day’s Range― - ―

52-Week Range₹126.75 - ₹207.00

Previous CloseN/A

Volume7.72K

Average Volume (3M)2.58K

Market Cap

₹2.94B

Enterprise Value₹4.67K

Total Cash (Recent Filing)₹759.95M

Total Debt (Recent Filing)₹0.00

Price to Earnings (P/E)8.4

Beta1.05

Next Earnings

Oct 21, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield1.29%

Share Statistics

EPS (TTM)18.43

Shares Outstanding19,004,000

10 Day Avg. Volume2,256

30 Day Avg. Volume2,581

Financial Highlights & Ratios

PEG Ratio1.86

Price to Book (P/B)0.38

Price to Sales (P/S)0.58

P/FCF Ratio-10.22

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Conservative Balance SheetLow leverage materially reduces financial risk across planting cycles and commodity volatility. A conservatively levered balance sheet preserves borrowing capacity for seed R&D, inventory funding and dealer credit, and lowers interest burden, supporting durable operational resilience.

Sustained Positive MarginsConsistent positive operating and net margins indicate the core seed business generates real economic profit. Durable margins enable reinvestment in breeding, processing quality and distribution, and provide a buffer against seasonality and input cost swings when cash conversion normalizes.

Proprietary Seed Model & GrowthA business model built on proprietary breeding and an established dealer network creates product differentiation and recurring seasonal demand. Meaningful revenue growth suggests commercial traction; this structural model supports scalable margins and long-term customer stickiness if variety performance persists.

Bears Say

Weak Cash GenerationNegative operating and free cash flow despite reported profits erodes funding flexibility and raises reliance on external financing or equity to fund inventory, seed production and R&D. Persistent weak cash conversion increases execution risk and can force cuts to growth investments.

Margin Compression & VolatilityA material decline in margins over recent years signals pressure from pricing, input costs or mix shifts. Sustained margin erosion reduces internal cash available for breeding and distribution expansion, and leaves less cushion for poor crop seasons, weakening long-term profitability resilience.

Moderate Returns On EquityROE near 6% indicates limited capital efficiency relative to alternative uses. Modest returns constrain the company's ability to self-fund aggressive breeding programs or scale distribution without diluting returns, potentially limiting long-term shareholder value creation.

Nath Bio-Genes (India) Ltd. News

Nath Bio-Genes Releases Investor Presentation on Unaudited Q3 and 9MFY26 Results

Nath Bio-Genes (India) Ltd. ( ($IN:NATHBIOGEN) ) has issued an announcement. Nath Bio-Genes (India) Ltd. has released an...

7M ago

Nath Bio-Genes Shuts Trading Window Ahead of Q3 FY26 Results

Nath Bio-Genes (India) Ltd. ( ($IN:NATHBIOGEN) ) has provided an update. Nath Bio-Genes (India) Ltd. has announced that...

8M ago

Nath Bio-Genes Ensures Regulatory Compliance with SEBI Regulations

An update from Nath Bio-Genes (India) Ltd. ( ($IN:NATHBIOGEN) ) is now available. Nath Bio-Genes (India) Ltd. has...

10M ago

Nath Bio-Genes Releases Q3 FY25 Financial Results

An update from Nath Bio-Genes (India) Ltd. ( ($IN:NATHBIOGEN) ) is now available. Nath Bio-Genes (India) Limited has...

2y ago

NATHBIOGEN FAQ

What was Nath Bio-Genes (India) Ltd.’s price range in the past 12 months?

Nath Bio-Genes (India) Ltd. lowest stock price was ₹126.75 and its highest was ₹207.00 in the past 12 months.

What is Nath Bio-Genes (India) Ltd.’s market cap?

Nath Bio-Genes (India) Ltd.’s market cap is ₹2.94B.

When is Nath Bio-Genes (India) Ltd.’s upcoming earnings report date?

Nath Bio-Genes (India) Ltd.’s upcoming earnings report date is Oct 21, 2026 which is in 63 days.

How were Nath Bio-Genes (India) Ltd.’s earnings last quarter?

Nath Bio-Genes (India) Ltd. released its earnings results on Jul 29, 2026. The company reported ₹16.976 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.

Is Nath Bio-Genes (India) Ltd. overvalued?

According to Wall Street analysts Nath Bio-Genes (India) Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Nath Bio-Genes (India) Ltd. pay dividends?

Nath Bio-Genes (India) Ltd. pays a Annually dividend of ₹2 which represents an annual dividend yield of 1.29%. See more information on Nath Bio-Genes (India) Ltd. dividends here

What is Nath Bio-Genes (India) Ltd.’s EPS estimate?

Nath Bio-Genes (India) Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Nath Bio-Genes (India) Ltd. have?

Nath Bio-Genes (India) Ltd. has 19,004,000 shares outstanding.

What happened to Nath Bio-Genes (India) Ltd.’s price movement after its last earnings report?

Nath Bio-Genes (India) Ltd. reported an EPS of ₹16.976 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.467%.

Which hedge fund is a major shareholder of Nath Bio-Genes (India) Ltd.?

Currently, no hedge funds are holding shares in IN:NATHBIOGEN

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Nath Bio-Genes (India) Ltd.

Nath Bio-Genes (India) Limited is dedicated to the development, preparation, and worldwide distribution of both hybrid and genetically modified (GM) seeds, catering to demand within India and internationally. Its business operations are organized into two main divisions: agricultural pursuits and trading endeavors. The company provides a wide array of seeds, including: Cereals: Maize, paddy, millet, wheat, and jowar. Fruits: Various fruit seed varieties. Fiber and Oil-Producing Crops: Notably cotton and mustard. Vegetables: A comprehensive selection such as chilli, okra, tomato, brinjal, bottle gourd, bitter gourd, sponge gourd, ridge gourd, cucumber, coriander, onion, sweet pepper, green peas, pumpkin, tinda, cabbage, and French beans. Additionally, Nath Bio-Genes supplies agricultural enhancement products, offering crop protection supplements like the WINPro GOLii, WINall, and Win Chi Win growth enhancers. It also provides forage supplements, NUTRIMAX GOLD and NUTRIMAX, specifically formulated to boost fodder production. The company disseminates its products via an extensive network that includes distributors, dealers, and its own processing facilities. Nath Bio-Genes (India) Limited was founded in 1979 and is based in Aurangabad, India.